Hepatitis C antibody prevalence in blood donors in different governorates in Egypt (Q38880759)

7 September 2017

Hepatitis C antibody prevalence in blood donors in different governorates in Egypt (English)

1 reference

7 September 2017

1 reference

0 references

1 reference

Arthur RR

1

1 reference

7 September 2017

Hassan NF

2

1 reference

7 September 2017

Abdallah MY

3

1 reference

7 September 2017

el-Sharkawy MS

4

1 reference

7 September 2017

Saad MD

5

1 reference

7 September 2017

Hackbart BG

6

1 reference

7 September 2017

Imam IZ

7

1 reference

7 September 2017

1 May 1997

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

7 September 2017

1 reference

7 September 2017

91

1 reference

7 September 2017

3

1 reference

7 September 2017

271-274

1 reference

High seroprevalence of hepatitis C infection among risk groups in Egypt.

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

High HCV prevalence in Egyptian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Screening blood donations for HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Infectivity of blood seropositive for hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

High prevalence of hepatitis C in Egyptian patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

Detection of antibodies to hepatitis C virus in U.S. blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990070-5

7 January 2021

10.1016/S0035-9203(97)90070-5

Identifiers

DOI

1 reference

7 September 2017

1 reference